多组学技术及其在肝细胞癌中的临床应用: 当前进展与未来机遇
杨万水， 蒋涵羽， 刘超， 魏靖伟， 周宇… - Chinese Medical …, 2021 - cmsj.cams.cn
… , partly due to the lack of analytical strategies towards the … chronic hepatitis B (CHB)developed
HCC and liver cirrhosis (LC)-… Malignancy characterization of hepatocellular carcinomas …
HCC and liver cirrhosis (LC)-… Malignancy characterization of hepatocellular carcinomas …
[PDF][PDF] 病毒性丙型肝炎患者的肝外表现
RV Shavkatovna, EI Normuxammadovna… - … RESEARCH OF THE … - naukarus.ru
… of fibrosis, cirrhosis and hepatocellular carcinoma in patients with chronic infection with hepatitis
B vi… Our calculations showed that from the end of vaccination until the time of absence or …
B vi… Our calculations showed that from the end of vaccination until the time of absence or …
NAFLD 与肝细胞癌的相关性研究进展
邴浩， 李异玲 - 实用肝脏病杂志, 2018 - manu43.magtech.com.cn
… and NAFLD/NASH-associated cirrhosis and NAFLD/NASH-… arise in the absence of overt
cirrhosis in patients with NASH,… hepatocellular carcinoma by chronic hepatitis B/C infection:A …
cirrhosis in patients with NASH,… hepatocellular carcinoma by chronic hepatitis B/C infection:A …
Toll 样受体在肝癌中作用的研究进展.
刘幸， 撒亚莲 - … of Kunming Medical University/Kunming Yike …, 2016 - search.ebscohost.com
… TLRs 可以参与慢性 乙型肝炎(chronic hepatitis B,CHB) 的免疫应 答.Momeni 等[15]的研究显示
,在检测… progresses to hepatocellular carcinoma in the absence of apparent cirrhosis [J].Int J …
,在检测… progresses to hepatocellular carcinoma in the absence of apparent cirrhosis [J].Int J …
长期接受恩替卡韦治疗的乙型肝炎肝硬化患者血清水通道蛋白8 和水通道蛋白9 变化及其临床意义探讨
郝玉婷， 林洁， 秦杰 - 实用肝脏病杂志, 2022 - manu43.magtech.com.cn
… Methods A total of 83 patients with hepatitis B-induced LC who received long-term entecavir
… Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B …
… Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B …
直接抗病毒药物改善HCV 相关肝细胞癌患者远期预后效果的Meta 分析.
周荃， 杨丽晖， 蒋芳清 - Journal of Clinical Hepatology …, 2021 - search.ebscohost.com
… in the risk prediction models for chronic hepatitis B -related hepatocellular carcinoma[ J]. J …
of patients with hepatocellular carcinoma and compensated hepatitis C virus -related cirrhosis …
of patients with hepatocellular carcinoma and compensated hepatitis C virus -related cirrhosis …
Toll 样受体4 与乙型肝炎的相关性
范文海， 陈青锋 - 临床肝胆病杂志, 2016 - lcgdbzz.org
… hepatitis B,in order to find new therapies for hepatitis B and new protocols which delay the
progression of hepatitis B to liver cirrhosis and liver cancer … between TLR4 and hepatitis B. …
progression of hepatitis B to liver cirrhosis and liver cancer … between TLR4 and hepatitis B. …
复方中药阻断逆转肝纤维化: 超越已知的前沿.
柏兆方， 湛小燕， 吕桂基， 杨永 - Journal of Clinical …, 2023 - search.ebscohost.com
… fectively reduce the development of chronic hepatitis B cirrhosis and liver cancer. There are
… ges in the treatment of liver fibrosis;however,due to a lack of strict and standardized clinical …
… ges in the treatment of liver fibrosis;however,due to a lack of strict and standardized clinical …
扩大慢性乙型肝炎抗病毒治疗适应证: 利大于弊.
韩超， 窦晓光 - Journal of Clinical Hepatology/Linchuang …, 2023 - search.ebscohost.com
… for chronic hepatitis B:… by hepatitis B virus (HBV),and without timely and effective antiviral
therapy,it will eventually develop into liver cirrhosis,liver failure or hepatocellular carcinoma (…
therapy,it will eventually develop into liver cirrhosis,liver failure or hepatocellular carcinoma (…
基于影像组学的深度学习评估肌少症对肝癌切除和移植患者预后的影响
Z LIU, Y WU, AA KHAN, L LU, J WANG… - … SCIENCE B, 2024 - jzus.zju.edu.cn
… in hepatocellular carcinoma[J]. Journal of Zhejiang University Science B, 2024, 25(1): 83-90. …
However, the lack of standardized diagnostic methods for sarcopenia limits their clinical use…
However, the lack of standardized diagnostic methods for sarcopenia limits their clinical use…